Bafna Pharmaceuticals Ltd. logo

Bafna Pharmaceuticals Ltd. (BAFNAPH)

Market Closed
11 Aug, 22:00
MSE MSE
278. 75
-5.65
-1.9866%
2.52B Market Cap
- P/E Ratio
- Div Yield
13,751 Volume
- Eps
284.4
Previous Close
Add Transaction
Day Range
278.75 278.75
Year Range
85.24 296
Want to track BAFNAPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bafna Pharmaceuticals Ltd. (BAFNAPH) Statistics

Valuation metrics

Market Cap 2.52B
Enterprise value 7.1B
Trailing P/E (ttm) 60.77
Forward P/E -
PEG ratio 0.36
Price/Sales (ttm) 4.48
Price/Book (mrq) 7.02
Enterprise Value/Revenue 4.71
Enterprise Value/EBITDA 36.42

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.65K
Average volume (90 days) 5.45K

Price summary

52-Week low 85.24
52-Week high 296
Beta -
50-Day moving average 229.8
200-Day moving average 156.18

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 26 Aug 2019

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.07%
Operating margin 0.07%

Operational effectiveness

Return on assets 0.06%
Return on equity 0.12%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 63.55
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.68
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.85
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 1.57%
Book value per share (mrq) 40.57

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -